en · de · es · fr · pt
cardarine-notes.peptides3626.com › Faq › Background And Regulatory History — Complete Guide

Background And Regulatory History — Complete Guide

By Editorial Desk · published 2026-07-28 · last reviewed 2026-08-01 · Faq

If you have been reading about GW501516 and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.

Updated 2026-08-01. Numbers and descriptions here follow the published literature rather than marketing material.

Background and Regulatory History

GW501516 acts on PPARδ, a nuclear receptor that helps regulate fatty acid oxidation and energy homeostasis. In animal studies, activation of this receptor was associated with increased endurance and changes in lipid metabolism. Human trials examined effects on blood lipids and other metabolic markers, but the compound did not advance to approval. Rodent studies later reported tumors in multiple tissues at doses used in those experiments. Whether those findings translate to human risk remains uncertain, and the clinical relevance of the animal data is still debated.

Regulatory bodies treat GW501516 as a prohibited substance in competitive sport. The World Anti-Doping Agency added it to the prohibited list, and it falls under classes covering metabolic modulators and hormone-related agents. It is not approved by drug regulators for human use, and it is not a lawful dietary supplement. Products sold under the cardarine name may contain unlisted ingredients or different compounds. Because no approved product exists, quality and identity are not guaranteed by pharmaceutical manufacturing standards.

Cardarine is a common name for the investigational chemical GW501516, also written GW-1516. It was developed as a peroxisome proliferator-activated receptor delta agonist for metabolic conditions such as dyslipidemia. Early research focused on lipid handling and energy use in skeletal muscle and other tissues. The compound was never approved as a medicine. In public discussion, it is often grouped with performance-enhancing substances, although its receptor target differs from that of anabolic steroids or selective androgen receptor modulators. Regulatory and health authorities have issued warnings about its use.

Identity and Pharmacological Mechanism

The compound is typically described as a laboratory compound rather than a therapeutic product. Published reports have explored its role in lipid disorders, insulin sensitivity, and exercise metabolism, yet no major drug regulator has approved it for medical use. Commercial samples sold under the cardarine name may vary in purity and identity. Analytical confirmation is therefore necessary when the material is discussed in scientific or regulatory contexts. Its classification as a prohibited substance in sport further shapes how it is studied and reported.

Cardarine is a common name for GW501516, a synthetic compound studied for its effects on lipid and glucose metabolism. It functions as an agonist at peroxisome proliferator-activated receptor delta, or PPARδ, a nuclear receptor that influences gene expression. The molecule is not a steroid, nor is it a selective androgen receptor modulator. It is also known in research and sports literature as GW-501516 and endurobol. Early laboratory work examined its metabolic activity in cell cultures and animal models.

Cardarine at a glance

PropertyValueNotes
Common nameCardarineCommon internet and media name.
Research codeGW501516Also written GW-1516.
Drug classPPARδ agonistNot a selective androgen receptor modulator.
Development statusDiscontinuedClinical development halted after rodent cancer findings.
Regulatory statusProhibited in sportListed by WADA; not approved as medicine.

Background and Regulatory Status

Sporting authorities added GW501516 to prohibited lists after it appeared in athlete samples and online markets. The World Anti-Doping Agency classifies it as a hormone and metabolic modulator, and its use can lead to an anti-doping rule violation. Some early laboratory work suggested effects on fatty acid oxidation and endurance-related metabolism in animals, but those findings do not establish safe or effective use in people. Reports of adverse events in humans are scarce and often anecdotal, which complicates risk assessment.

Legal status varies by country. In some places, cardarine is controlled under medicines or psychoactive substances laws; in others, it may be sold with minimal oversight as a research chemical. Customs agencies have intercepted shipments, and several national health agencies have issued warnings about products marketed for bodybuilding or performance enhancement. The lack of a standardized pharmaceutical supply means identity, purity, and contamination levels can differ widely between samples. These factors make cardarine a regulatory and public health concern rather than a conventional prescription drug.

Related pages on this site

Regulatory Status and Detection Context

Cardarine is not approved for human therapeutic use in any major jurisdiction. It appears on the World Anti-Doping Agency Prohibited List as a PPARδ agonist within the hormone and metabolic modulators category. Sports organizations test for it because it has been detected in athlete samples and seized products. Regulatory actions against marketed research chemical versions have occurred in several countries, though enforcement varies. Availability through unregulated channels complicates oversight.

Analytical laboratories typically identify cardarine and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is a common matrix in anti-doping testing, while blood and tissue may be used in research settings. Detection windows depend on the assay, the sample matrix, and the compound's metabolism. Because cardarine is extensively metabolized, laboratories often target specific metabolites to improve sensitivity and confirmation. Reference standards are required for reliable quantification. Method validation includes checks for selectivity, linearity, and carryover.

Supporting material

== Pokeweed antiviral protein == Pokeweed antiviral protein is a ribosome inactivating protein that provides pokeweed plants protection against both viral and fungal infections. It also protects other types of plants that have genetically engineered to express RAP that do not normally do so. Recombinant pokeweed antiviral protein has also been proposed as a treatment of human diseases such as AIDS and cancer.

==== Noncanonical pathways ==== The noncanonical planar cell polarity (PCP) pathway does not involve β-catenin. It does not use LRP-5/6 as its co-receptor and is thought to use NRH1, Ryk, PTK7 or ROR2. The PCP pathway is activated via the binding of Wnt to Fz and its co-receptor. The receptor then recruits Dsh, which uses its PDZ and DIX domains to form a complex with Dishevelled-associated activator of morphogenesis 1 (DAAM1). Daam1 then activates the small G-protein Rho through a guanine exchange factor. Rho activates Rho-associated kinase (ROCK), which is one of the major regulators of the cytoskeleton. Dsh also forms a complex with rac1 and mediates profilin binding to actin. Rac1 activates JNK and can also lead to actin polymerization. Profilin binding to actin can result in restructuring of the cytoskeleton and gastrulation.

[The] mental troubles must have ... a relation with the formation of cellulo-connective groupings, which become more or less fixed. The cellular bodies may remain altogether normal, their cylinders will not have any anatomical alterations; but their multiple liaisons, very variable in normal people, may have arrangements more or less fixed, which will have a relation with persistent ideas and deliria in certain morbid psychic states. For Moniz, "to cure these patients", it was necessary to "destroy the more or less fixed arrangements of cellular connections that exist in the brain, and particularly those which are related to the frontal lobes", thus removing their fixed pathological brain circuits. Moniz believed the brain would functionally adapt to such injury. Unlike the position adopted by Burckhardt, it was unfalsifiable according to the knowledge and technology of the time, as the absence of a known correlation between physical brain pathology and mental illness could not disprove his thesis.

Venous access is any method used to access the bloodstream through the veins, either to administer intravenous therapy such as medication, or fluid, parenteral nutrition, to obtain blood for analysis, or to provide an access point for blood-based treatments such as dialysis or apheresis. Access is most commonly achieved via the placement of a central venous catheter, a Seldinger technique, and guidance tools such as ultrasound and fluoroscopy can also be used to assist with access location.

Despite its small window for detection, two primary methods of testing have been developed for hGH, one being an isoform test which detects changes in growth hormone structure in the blood, and the markers test, which detects changes in serum protein ratios.

Sources: en.wikipedia.org

Notes from published material

== External links == Imidazoline+Receptors at the U.S. National Library of Medicine Medical Subject Headings (MeSH) imidazoline receptor 2 at the U.S. National Library of Medicine Medical Subject Headings (MeSH) imidazoline I1 receptors at the U.S. National Library of Medicine Medical Subject Headings (MeSH)

== Further reading == Moskin, Julia (August 19, 2014). "Brisket Is Worth the Wait". The New York Times. Retrieved March 17, 2015. Green, Aliza (2005). Field Guide to Meat. Philadelphia: Quirk Books. ISBN 1-931686-79-3.

== Further reading == Hill, A. V.; Long, C. N. H.; Lupton, H. (1924). "Muscular Exercise, Lactic Acid, and the Supply and Utilisation of Oxygen". Proceedings of the Royal Society B: Biological Sciences. 96 (679): 438–75. doi:10.1098/rspb.1924.0037. JSTOR 81203. Laforgia, J.; Withers, R. T.; Gore, C. J. (2006). "Effects of exercise intensity and duration on the excess post-exercise oxygen consumption". Journal of Sports Sciences. 24 (12): 1247–64. doi:10.1080/02640410600552064. PMID 17101527. S2CID 25579756. Lee, C. G. (2003). "Excess post-exercise oxygen consumption in adult sockeye (Oncorhynchus nerka) and coho (O. Kisutch) salmon following critical speed swimming". Journal of Experimental Biology. 206 (18): 3253–60. doi:10.1242/jeb.00548. PMID 12909706. Thornton, M. K.; Potteiger, J. A. (2002). "Effects of resistance exercise bouts of different intensities but equal work on EPOC". Medicine & Science in Sports & Exercise. 34 (4): 715–22. doi:10.1249/00005768-200204000-00024. PMID 11932584. Gore, C. J.; Withers, R. T. (1990). "The effect of exercise intensity and duration on the oxygen deficit and excess post-exercise oxygen consumption". European Journal of Applied Physiology and Occupational Physiology. 60 (3): 169–74. doi:10.1007/BF00839153. PMID 2347316. S2CID 11724610. Lee, C. G.; Devlin, R. H.; Farrell, A. P. (2003). "Swimming performance, oxygen consumption and excess post-exercise oxygen consumption in adult transgenic and ocean-ranched coho salmon". Journal of Fish Biology. 62 (4): 753–66. doi:10.1046/j.1095-8649.2003.00057.x.

In 2003, following the Soccer Australia team's failure to qualify for the 2002 FIFA World Cup, allegations of fraud and mismanagement were levelled at Soccer Australia by elements within the Australian press including the ABC. Soccer Australia commissioned an independent inquiry known as the Crawford Report as a result of the Australian government's threat to withdraw funding to the sport. Any political interference would have constituted a breach of FIFA statutes. The findings of the report were critically analysed by the board of Soccer Australia who believed that the recommendations contained therein were not capable of being implemented. The report recommended, among other things, the reconstitution of the organisation with an interim board headed by prominent businessman Frank Lowy. Some three months after Lowy's appointment, Soccer Australia was placed into liquidation and the Australian Soccer Association (ASA) was created and seized control of the premier soccer competitions and teams without encompassing the Crawford Report recommendations and effectively disenfranchised all other organisations and parties with an interest in Soccer Australia. The Australian government provided approximately $15 million to the ASA. On 1 January 2005, ASA renamed itself Football Federation Australia (FFA), aligning with the international usage of the name "football" in preference to "soccer" and, by a more distinct name, distancing itself from the failings of the former Soccer Australia. It coined the phrase "old soccer, new football" to emphasise this.

Sources: en.wikipedia.org

Background from the literature

As early as 1960, ZAPU's predecessor, the National Democratic Party (NDP), had established informal contacts with the Soviet Union and Czechoslovakia, and discussed the possibility of obtaining military training in Eastern Europe for its members. In July 1962, Nkomo visited Moscow and discussed plans for a ZAPU-led armed uprising in Rhodesia. He made formal requests for Soviet funding and arms for ZIPRA, explaining that "for these purposes ZAPU needs arms, explosives, revolvers...the party also needs money to bribe persons who guard important installations, to carry out sabotage". The Soviets agreed to supply ZAPU with limited funds beginning in 1963, and increased its level of financial support after UDI. In 1963, ZIPRA also made its first formal request to the Soviet Union for military training. The Soviets began training ZIPRA militants in guerrilla warfare in early 1964. Nkomo's public endorsement of a violent strategy confirmed white politicians' opposition to ZAPU and fed their negative attitudes towards black nationalists at large. In response to the formation of ZIPRA, the Rhodesian government banned ZAPU, driving that party's supporters underground. It also passed draconian security legislation restricting the right to assembly and granting the security forces broad powers to crack down on suspected political subversives. For the first time, the death sentence was also introduced for any act of politically inspired terrorism which involved arson or the use of explosives.

The following is a partial list of the "D" codes for Medical Subject Headings (MeSH), as defined by the United States National Library of Medicine (NLM). This list continues the information at List of MeSH codes (D12.644). Codes following these are found at List of MeSH codes (D13). For other MeSH codes, see List of MeSH codes. The source for this content is the set of 2006 MeSH Trees from the NLM.

== Synthesis == Fentanyl is a 4-anilinopiperidine class synthetic opioid. The synthesis of Fentanyl is accomplished by one of four main methods as reported in the scientific literature: the Janssen, Siegfried, Gupta, or Suh method.

Sources: en.wikipedia.org

Frequently asked questions

Is cardarine a selective androgen receptor modulator?

No. Cardarine is a PPARδ agonist, while selective androgen receptor modulators act on androgen receptors. The two classes differ in receptor target and downstream effects.

Why did clinical development stop?

Preclinical rodent studies reported cancers, including liver and bladder tumors, at tested doses. The human relevance of those findings is uncertain, but development was discontinued. No approved human product resulted.

Is cardarine approved for medical use?

No. It remains an investigational compound without approved therapeutic labeling. Sports regulators prohibit its use, and health agencies have warned against consuming it.

What is cardarine?

Cardarine is a common name for GW501516, a synthetic PPARδ agonist. It is not a steroid or a selective androgen receptor modulator. It was developed and studied as a research compound for metabolic pathways.

Network